Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.42 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.42 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.42 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6685951 | 1.00 | AHCY (0.46) | AHCYADORA2ACYP2C19ADORA2BCDK1 | |
| SCHEMBL20798007 | 0.90 | ADORA2A (0.43) | ADORA2AADORA2BADORA3ADORA1PI4KA | |
| SCHEMBL226038 | 0.90 | ADORA2A (0.43) | ADORA2AADORA2BADORA3ADORA1PI4KA | |
| SCHEMBL6538264 | 0.89 | ADORA2A (0.57) | ADORA2ACDK1ADORA3ADORA1LMNA | |
| SCHEMBL2458484 | 0.87 | BLM (0.44) | CYP2C19ADORA3LMNA | |
| Phosphoric Acid SCHEMBL1300003 | 0.85 | RNASEL (0.42) | ADORA2AADORA2BADORA3ADORA1PI4KA | |
| SCHEMBL18537398 | 0.85 | PI4KA (0.55) | AHCYADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL3794703 | 0.85 | PI4KA (0.55) | AHCYADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL18680910 | 0.85 | PI4KA (0.55) | AHCYADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL16258664 | 0.85 | PI4KA (0.55) | AHCYADORA2AADORA2BADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020257275-A1 | IMPROVED IN VITRO TRANSCRIPTION PURIFICATION PLATFORM | ARCTURUS THERAPEUTICS, INC. (US) | 2020-12-24 | — | — | WO | claimed |
| EP-3681513-A1 | RNAI AGENTS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3), AND METHODS OF USE | Arrowhead Pharmaceuticals, Inc. (US) | 2020-07-22 | — | — | EP | claimed |
| WO-2019055633-A1 | RNAI AGENTS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3), AND METHODS OF USE | Arrowhead Pharmaceuticals, Inc. (US) | 2019-03-21 | — | — | WO | claimed |
| WO-2024137993-A2 | ENGINEERED GUIDE RNAS AND POLYNUCLEOTIDES | SHAPE THERAPEUTICS INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-4359078-A2 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | Versameb AG (CH) | 2024-05-01 | — | — | EP | disclosed |
| EP-4359533-A2 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | Versameb AG (CH) | 2024-05-01 | — | — | EP | disclosed |
| US-20240117354-A1 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | VERSAMEB AG (CH) | 2024-04-11 | — | — | US | disclosed |
| US-20240117361-A1 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | VERSAMEB AG (CH) | 2024-04-11 | — | — | US | disclosed |
| CN-117813380-A | Compositions and methods for modulating expression of genes | 维萨梅布有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-116710108-A | Compositions and methods for simultaneous modulation of gene expression | 维萨梅布有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230183746-A1 | COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS | Sixfold Bioscience Ltd. (GB) | 2023-06-15 | — | — | US | disclosed |
| EP-2331129-A1 | COMPOSITION COMPRISING A COMPLEXED (M)RNA AND A NAKED MRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF | Curevac GmbH (DE) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010037408-A1 | COMPOSITION COMPRISING A COMPLEXED (M)RNA AND A NAKED MRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF | CUREVAC GMBH (DE) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010037539-A1 | COMPOSITION COMPRISING A COMPLEXED (M)RNA AND A NAKED MRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF | CUREVAC GMBH (DE) | 2010-04-08 | — | — | WO | disclosed |
| WO-2009046739-A1 | COMPOSITION FOR TREATING PROSTATE CANCER (PCA) | CUREVAC GMBH (DE) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009046738-A1 | COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC) | CUREVAC GMBH (DE) | 2009-04-16 | — | — | WO | disclosed |
| EP-1525209-A2 | 1'-, 2'- AND 3' -MODIFIED NUCLEOSIDE DERIVATIVES FOR TREATING FLAVIVIRIDAE INFECTIONS | Idenix (Cayman) Limited (KY) | 2005-04-27 | — | — | EP | disclosed |
| US-20040214198-A1 | Allele-targeted RNA interference | UNIVERSITY OF MASSACHUSETTS | 2004-10-28 | — | — | US | disclosed |
| WO-2004046324-A2 | ALLELE-TARGETED RNA INTERFERENCE | UNIVERSITY OF MASSACHUSETTS (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004003000-A2 | 1’-, 2'- AND 3'- MODIFIED NUCLEOSIDE DERIVATIVES FOR TREATING FLAVIVIRIDAE INFECTIONS | IDENIX (CAYMAN) LIMITED (KY) | 2004-01-08 | — | — | WO | disclosed |